TORONTO, March 26, 2026 (GLOBE NEWSWIRE)-- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...
TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...
Evommune (NYSE:EVMN) is a clinical-stage biotechnology company focused on developing therapies for chronic inflammatory ...
The multipronged organization has a lab space on the working waterfront and an academy, the Gloucester Biotechnology Academy, ...
USANewsGroup.com News Commentary-- The global cell therapy manufacturing market is hitting a pivotal inflection point. It's ...
Cartography Biosciences, Inc., a clinical-stage biotechnology company advancing a differentiated pipeline of antibody-based cancer therapies, today announced that Gilead Sciences, Inc. has exercised ...
Radiopharm Theranostics Ltd (ASX:RAD, OTC:RDPTF, NASDAQ:RADX) has dosed the first patient in a Phase 1 clinical trial of its lead prostate cancer candidate RAD 402, marking the company’s entry into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results